- Home
- Primary Care
- Dupilumab as a Novel Therapy for Difficult-to-Treat Chronic Spontaneous Urticaria: A Case Report

5d3 min read
Medical Article
Introduction: Chronic spontaneous urticaria (CSU), also known as chronic idiopathic urticaria, is a common condition characterized by recurrent, pruritic, erythematous wheals persisting for more than six weeks without a specific known cause. CSU affects approximately 0.5% to 1.8% of the adult population and can significantly impact quality of life

Dupilumab as a Novel Therapy for Difficult-to-Treat Chronic Spontaneous Urticaria: A Case Report
1 Reached
Similar Content

ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes

Catheter Ablation for Atrial Fibrillation with HF
691 Reached

Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes

FOURIER Trial: Efficacy of Evolocumab in Managing Cardiovascular Events
563 Reached3 Comments

Headache with Clinically Non-functioning Pituitary Adenoma
818 Reached1 Comments4 Likes